Close Menu

During a recent Science Online New York City discussion hosted by Nature.com and Ars Technica, panelist Mark Hahnel said that of the nearly 1,000 figures he generated during his PhD studies, only 20 were published in traditional outlets and made available to others. Because of his desire to both share his results and get credit for them, Hahnel developed FigShare, an open-source repository for raw data, figures, citations, and links to additional research, among other things — all of which is published under a Creative Commons license.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.